产品编号：D452517
产品规格：2.5mg
产品价格：面议
| 标准品编号: | D452517 |
| 名称: | 3α,7α-Dihydroxycoprostanic Acid-d3 |
| 别名: | (3α,5β,7α)-3,7-Dihydroxycholestan-26-oic Acid-d3; 3α,7α-Dihydroxy-5β-cholestan-26-oic Acid-d3; 3α,7α-Dihydroxy-5β-cholestanoic Acid-d3; 3α,7α-Hydroxy-5β-cholestan-26-oic Acid-d3; (3α,5β,7α)-3,7-Dihydroxy-cholestan-26-oic-27,27,27-d3 Acid; |
| CAS号: | 338976-76-4 |
| 参考CAS号: | 类似: 17974-66-2 |
| 分子式: | C₂₇H₄₃D₃O₄ |
| 外观: | 白色至白色固体 |
| 熔点: | 97 - 100°C |
| 分子量: | 437.67 |
| 储存: | 冰箱保存 |
| 溶解性: | Chloroform (Slightly), Methanol (Slightly) |
| 种类: | Standards; Steroids; Isotopic Labeled Analogues; |
| 应用: | 3α,7α-Dihydroxycoprostanic Acid-d3 is a labelled analogue of 3α,7α-Dihydroxycoprostanic Acid (D452515), a precursor of Cholic Acid (C432600), it undergoes side chain oxidation during the synthesis of bile acids. It was found that Zellweger’s syndrome patients have abnormal mitochondrial structure, the organelle that is responsible for the side chain oxidation, and as a consequence, excess amounts of 3α,7α-Dihydroxycoprostanic Acid. |
| 参考文献 | |
